Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2023 | Management of brain metastases associated with lung cancer

Samreen Ahmed • 27 Mar 2023
ELCC 2023
Lung Cancer

Samreen Ahmed, FRCP, MD, MBBS, MSc (onc), University Hospitals of Leicester, Leicester, UK, comments on her contribution at the European Lung Cancer Congress (ELCC) 2023 in Copenhagen, Denmark, discussing the control of brain metastases that commonly arise in patients with mutationally-driven lung cancer. This interview took place at ELCC 2023 in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Samreen Ahmed

3:29
Novel strategies to treating brain metastases in lung cancer
Samreen Ahmed • 27 Mar 2023
0:54
Early lung cancer at ELCC 2023
Samreen Ahmed • 27 Mar 2023
3:06
Highlights from the BTOG 2023 therapeutics symposium
Samreen Ahmed • 26 Apr 2023
1:02
BTOG 2022 highlights: Prehabilitation and psycho-oncology
Samreen Ahmed • 28 Jan 2022

Related Videos

2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals